ADMA Biologics Inc
(NAS:ADMA)
$
17.67
0.26 (1.49%)
Market Cap: 4.12 Bil
Enterprise Value: 4.14 Bil
PE Ratio: 62.18
PB Ratio: 17.75
GF Score: 68/100 ADMA Biologics Inc at Jefferies Virtual Plasma Summit Transcript
Mar 11, 2021 / 04:20PM GMT
Release Date Price:
$2.16
(+1.89%)
Anthony Charles Petrone
Jefferies LLC, Research Division - Healthcare Analyst
Welcome everyone to the Jefferies First Annual Global Plasma Summit. With us up next, we have Adam Grossman and Brian Lenz, CEO and CFO of ADMA Biologics. We have 30 minutes allotted for a fireside chat session. So we look forward to the segment, and thank you both for joining us this year.
Brian Lenz
ADMA Biologics, Inc. - Executive VP & CFO
Thank you for having us.
Adam S. Grossman
ADMA Biologics, Inc. - Co-Founder, President, CEO & Director
Thank you very much, Anthony.
Questions & Answers
Anthony Charles Petrone
Jefferies LLC, Research Division - Healthcare Analyst
And maybe where we're starting off, Adam, is a little bit on a look back at 2020 and where we sit as of March, mid-March now we're approaching, it is the 1-year anniversary for most of COVID-19. So maybe a moment on how 2020 played out for ADMA and what are the most updated views as we sit here at the 1-year
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot